HF Sinclair Corporation Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? HF Sinclair Corporation Common Stock trades at $122.8 (market cap $21.46B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B). The key difference: HF Sinclair Corporation Common Stock is far larger — about 3.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and HF Sinclair Corporation Common Stock pays a 1.74% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HF Sinclair Corporation Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DINO | IOVA | |
|---|---|---|
Market Cap | $21.46B | $6.04B |
Volume | 2,430,580 | 14,805,993 |
Sector | Energy | Health |
52-Week High | $120.72 | $14.82 |
52-Week Low | $45.88 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $22.44B | $5.97B |
Dividend Yield | 1.74% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.
Read more on DINO →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →